基于切线野的容积旋转调强放疗用于晚期左乳腺癌
研究纳入23例改良根治术后需区域淋巴结照射的晚期左乳腺癌患者,其中17例采用基于切线野的容积旋转调强放疗(TVMAT)、6例采用传统容积旋转调强放疗(VMAT)设计计划。两组靶区适形指数与均匀性指数无统计学差异,但TVMAT使右侧乳腺、双肺和心脏的平均剂量及低剂量参数大幅降低。作者认为TVMAT在保持疗效的同时显著降低危及器官剂量,高度推荐用于乳腺癌尤其是需淋巴结照射的左侧疑难病例。
要点
- TVMAT组17例与传统VMAT组6例的靶区适形指数、均匀性指数无统计学差异。
- TVMAT使右侧乳腺、右肺、左肺、心脏平均剂量分别降低53.1%、37.7%、8.8%、21.2%。
- TVMAT使上述危及器官的低剂量参数V10、V5也明显降低。
核心结论
- TVMAT在保持靶区治疗效力与VMAT相当的同时,大幅降低危及器官所受辐射剂量。
- 作者高度推荐将TVMAT用于乳腺癌放疗,尤其是需淋巴结照射的左侧疑难病例。
研究设计与样本
- 共评估23例接受改良根治术并需辅助放疗(含淋巴结照射)的晚期左乳腺癌患者的放疗计划。
- 23份计划中17份采用TVMAT技术设计,6份采用传统VMAT设计。
- TVMAT与VMAT的主要区别在于弧计划中设置了特定角度范围内无 monitor unit(MU)输出的避开扇区,共5个部分弧内包含5个扇区。
- 比较TVMAT与VMAT的靶区、右侧乳腺、双侧肺和心脏的剂量学参数。
主要发现
- 两组靶区适形指数分别为0.98 ± 0.02与0.98 ± 0.03(P = 0.431),均匀性指数分别为0.12 ± 0.03与0.11 ± 0.05(P = 0.177),差异无统计学意义。
- 采用TVMAT后,右侧乳腺、右肺、左肺、心脏的平均剂量分别降低53.1%、37.7%、8.8%、21.2%。
- 采用TVMAT后,V10分别降低:右侧乳腺72.3%、右肺86.1%、左肺12.5%、心脏25.1%。
- 采用TVMAT后,V5分别降低:右侧乳腺56.5%、右肺28.3%、左肺12.7%、心脏18.2%。
临床怎么用
- 作者高度推荐将TVMAT用于乳腺癌放疗,尤其是需淋巴结照射的左侧疑难病例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To introduce the benefits of tangent-based volumetric modulated arc therapy (TVMAT), an innovative radiotherapy planning technique, compared with traditional volumetric modulated arc therapy (VMAT) for advanced left breast cancer needing nodal irradiation. MATERIALS AND METHODS: Twenty-three patients with advanced left breast cancer who had received modified radical mastectomy (MRM) and needed adjuvant radiotherapy including nodal irradiation were assessed. Among 23 radiotherapy treatment plans, 17 plans were designed by using TVMAT technique and 6 plans were designed by using traditional VMAT. The main difference of TVMAT from VMAT was that the area of avoidance sector within specific degrees of angle that had no monitor unit (MU) delivery was used in the arc planning, including a total of 5 sectors in 5 partial arcs. The dosimetries of planning target volume (PTV), right breast, bilateral lungs, and heart between TVMAT and VMAT were compared. RESULTS: The conformity index (CI) and homogeneity index (HI) of PTV between two groups were statistically equivalent (CI: 0.98 ± 0.02 and 0.98 ± 0.03, P = 0.431; HI: 0.12 ± 0.03 and 0.11 ± 0.05, P = 0.177), which indicated that the treatment efficacy of the plans regarding TVMAT was compatible with VMAT. However, all neighboring organs at risk (OAR) showed a great percentage of reduction in mean doses (right breast: 53.1%, right lung: 37.7%, left lung: 8.8%, heart: 21.2%) and low dose parameters (V10: right breast: 72.3%, right lung: 86.1%, left lung: 12.5%, heart: 25.1%; V5: right breast: 56.5%, right lung: 28.3%, left lung: 12.7%, heart: 18.2%) by using TVMAT. CONCLUSION: TVMAT greatly decreases the radiation doses delivered to the OAR with maintained therapeutic efficacy. It is highly recommended for treating breast cancer, especially for difficult cases with left side disease needing nodal irradiation.
引用
- Yu PC, Wu CJ, Nien HH, et al. Tangent-based volumetric modulated arc therapy for advanced left breast cancer. Radiat Oncol. 2018. PMID: 30486829. doi:10.1186/s13014-018-1167-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。